Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Carl Graham"'
Autor:
Matthew A. Brown, Katie Bechman, Michael H. Malim, Katie J. Doores, Catherine H. Smith, Sam Norton, Thomas Lechmere, Hataf Khan, F. Meynell, Timothy Tree, Tejus Dasandi, Jonathan Barker, Kamila Sychowska, Antony Raharja, Satveer K. Mahil, James Galloway, Carl Graham, Clara Domingo-Vila, Andrew P. Cope, David Baudry, Emily Pollock
Publikováno v:
The Lancet. Rheumatology
Mahil, S K, Bechman, K, Raharja, A, Domingo-Vila, C, Baudry, D, Brown, M A, Cope, A P, Dasandi, T, Graham, C, Khan, H, Lechmere, T, Malim, M H, Meynell, F, Pollock, E, Sychowska, K, Barker, J N, Norton, S, Galloway, J B, Doores, K J, Tree, T & Smith, C H 2022, ' Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression : a longitudinal cohort study ', The Lancet Rheumatology, vol. 4, no. 1, pp. e42-e52 . https://doi.org/10.1016/S2665-9913(21)00333-7
Mahil, S K, Bechman, K, Raharja, A, Domingo-Vila, C, Baudry, D, Brown, M A, Cope, A P, Dasandi, T, Graham, C, Khan, H, Lechmere, T, Malim, M H, Meynell, F, Pollock, E, Sychowska, K, Barker, J N, Norton, S, Galloway, J B, Doores, K J, Tree, T & Smith, C H 2022, ' Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression : a longitudinal cohort study ', The Lancet Rheumatology, vol. 4, no. 1, pp. e42-e52 . https://doi.org/10.1016/S2665-9913(21)00333-7
Background: COVID-19 vaccines have robust immunogenicity in the general population. However, data for individuals with immune-mediated inflammatory diseases who are taking immunosuppressants remains scarce. Our previously published cohort study showe
Autor:
Sam Norton, Jeffery Seow, Andrew P. Cope, Satveer K. Mahil, Jonathan Barker, Tejus Dasandi, Katie Bechman, Michael H. Malim, Matthew A. Brown, Antony Raharja, F. Meynell, Timothy Tree, Katie J. Doores, David Baudry, Thomas Lechmere, Emily Pollock, James Galloway, Catherine H. Smith, Carl Graham, Kamila Sychowska, Clara Domingo-Vila
Publikováno v:
The Lancet. Rheumatology
Summary Background Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfi